Table: Taiko Pharmaceutical - 6-MTH group results

Taiko Pharmaceutical

09/11/2018 06:00

Nov 9 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2018        Sep 30, 2017     Mar 31, 2019 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               3.83                3.63             9.36     
                   (+5.3 pct)          (+22.0 pct)      (-1.1 pct)  
  Operating          644 mln             502 mln           1.63     
                   (+28.1 pct)         (+6.0 pct)       (-12.2 pct) 
  Recurring          603 mln             382 mln           1.43     
                   (+57.7 pct)         (+20.1 pct)      (-8.8 pct)  
  Net                448 mln             276 mln           1.01     
                   (+62.3 pct)         (+8.5 pct)       (-7.8 pct)  
  EPS               31.43 yen           19.54 yen        70.94 yen  
  EPS Diluted       31.37 yen           19.47 yen                   
  Ann Div                               25.00 yen        25.00 yen  
  -Q2 div           10.00 yen              NIL                      
  -Q4 div                               25.00 yen        15.00 yen  
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T